Lixte Biotechnology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LIXT and other ETFs, options, and stocks.About LIXT
Lixte Biotechnology Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of developing a drug class called protein phosphatase 2A inhibitors. The firm is also involved in utilizing biomarker technology to identify enzyme targets associated with serious common diseases and then designing novel compounds to attack those targets.
CEOGeordan G. Pursglove
CEOGeordan G. Pursglove
Employees2
Employees2
HeadquartersPasadena, California
HeadquartersPasadena, California
Founded2005
Founded2005
Employees2
Employees2
LIXT Key Statistics
Market cap9.53M
Market cap9.53M
Price-Earnings ratio-2.74
Price-Earnings ratio-2.74
Dividend yield—
Dividend yield—
Average volume12.30M
Average volume12.30M
High today$4.15
High today$4.15
Low today$3.13
Low today$3.13
Open price$4.15
Open price$4.15
Volume571.96K
Volume571.96K
52 Week high$4.45
52 Week high$4.45
52 Week low$0.64
52 Week low$0.64
People also own
Based on the portfolios of people who own LIXT. This list is generated using Robinhood data, and it’s not a recommendation.